Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib

BACKGROUND: Thymidine kinase 1 (TK1) is a cell cycle-regulated enzyme with peak expression in the S phase during DNA synthesis, and it is an attractive biomarker of cell proliferation. Serum TK1 activity has demonstrated prognostic value in patients with early-stage breast cancer. Because cyclin-dep...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagegni, Nusayba, Thomas, Shana, Liu, Ning, Luo, Jingqin, Hoog, Jeremy, Northfelt, Donald W., Goetz, Matthew P., Forero, Andres, Bergqvist, Mattias, Karen, Jakob, Neumüller, Magnus, Suh, Edward M., Guo, Zhanfang, Vij, Kiran, Sanati, Souzan, Ellis, Matthew, Ma, Cynthia X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5699111/
https://www.ncbi.nlm.nih.gov/pubmed/29162134
http://dx.doi.org/10.1186/s13058-017-0913-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5699111/
https://www.ncbi.nlm.nih.gov/pubmed/29162134
http://dx.doi.org/10.1186/s13058-017-0913-7

Ejemplares similares